ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1448	National Cancer Institute	Html	en	Bladder and Other Urothelial Cancers Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for bladder cancer.	bladder cancers 0.459113 individual developing bladder 0.462762 bladder cancer patients 0.501836 Cancer Statistics Review 0.390961 transitional cell carcinoma 0.372436 American Cancer Society 0.389675 bladder cancer 0.911425 Bladder histological changes 0.431525 bladder cancer outcome 0.469139 bladder cancer cases 0.467655 Malignant bladder tumors 0.429947 bladder neoplasms 0.417201 bladder tumours 0.413309 repetitive hematuria screening 0.375531 bladder cancer risk 0.493294 bladder tumors 0.476533 superficial bladder cancer 0.470192 hematuria screening studies 0.380947 bladder toxicity 0.421878 Natl Cancer Inst 0.460204 newly diagnosed bladder 0.471386 Bladder Cancer Group 0.465328 metastatic bladder cancer 0.508614 neuropathic bladder 0.420139 et al. 0.424244	SEER Cancer Statistics 0.388904 bladder carcinogenesis 0.425543 bladder wall 0.415168 bladder cancer mortality 0.489217 bladder tumor antigen 0.4299 bladder cancer. 0.44027 urothelial bladder cancer 0.487451 Cancer Epidemiol Biomarkers 0.435283 urothelial cancer 0.372416 smoking related bladder 0.437945 PUBMED Abstract 0.468199 hematuria home screening 0.413339 bladder cancer case-fatality 0.488876 invasive bladder cancer 0.504621 Superficial bladder tumor 0.43348 National Cancer Institute 0.389198 Bladder cancer incidence 0.470999 bladder malignancies 0.448894 Epidemiol Biomarkers Prev 0.405245 bladder tumor incidence 0.430849 Bladder cancer screening 0.490371 Abstract 0.469966 recurrent bladder tumors 0.444789 urinary bladder cancer 0.487624	CLICK HERE
1526	National Cancer Institute	Html	en	Nasopharyngeal Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of nasopharyngeal cancer.	clinical trial 0.341084 treatment 0.278725 clinical trial search 0.201632 cancer clinical trials 0.224875 lymph nodes 0.503913 radiation therapy 0.653094	National Cancer Institute 0.229813 cancer 0.952582 nasopharyngeal cancer 0.779979 clinical trials 0.675026 affected lymph nodes 0.35443	CLICK HERE
1692	National Cancer Institute	Html	en	Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®)–Patient Version	Expert-reviewed information summary about the use of nutrition and dietary supplements for reducing the risk of developing prostate cancer or for treating prostate cancer.	advanced prostate cancer 0.462339 anticancer effects 0.463801 clinical trial search 0.473734 green tea extract 0.477186 medical condition 0.458517 PSA levels 0.542556 clinical trials 0.664244 hormone-refractory prostate cancer 0.474056 U.S. Food 0.502589 early prostate cancer 0.465338 placebo 0.450024 laboratory studies 0.464618 prostate cancer cells 0.484177 prostate cancer risk 0.582265 food products 0.450637 prostate specific antigen 0.47312 prostate cancer patients 0.605367 population studies 0.543492 Prostate cancer deaths 0.462733 effects 0.499767 prostate cancer rates 0.456143 lycopene 0.466211 prostate cancers 0.457956 treatment 0.466735 study 0.482571	prostate cancer prevention 0.485364 androgen-independent prostate cancer 0.473958 tumor cells 0.455948 United States 0.574219 recurrent prostate cancer 0.457873 Drug Administration 0.504644 NCI-supported cancer 0.451146 products 0.463319 high-grade prostate cancer 0.459874 selenium 0.479361 dietary supplements 0.709022 studies 0.641892 general information 0.454636 green tea 0.628302 animal studies 0.638323 professional version 0.461561 low-grade prostate cancer 0.456901 label claims 0.456268 mixed results 0.4651 prostate cancer 0.981204 cancer clinical trials 0.48181 selenium supplements 0.463263 aggressive prostate cancer 0.460411 Laboratory/Animal/Preclinical Studies section 0.507788	CLICK HERE
1848	National Cancer Institute	Html	es	Tratamiento del cáncer de piel (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de piel.	Compton CC 0.427006 ángulo nariz-mejilla 0.312075 Cutaneous squamous 0.410175 criocirugía frente 0.310658 skin cancers 0.337834 señalización tipo erizo 0.316126 basal-cell carcinoma 0.31436 American Cancer Society 0.31065 Casciato DA 0.3104 7th ed 0.425796 Dermatol Surg Oncol 0.322688 TFD frente 0.31135 cutaneous carcinomas 0.448478 Mohs surgery is 0.310939 Plast Reconstr Surg 0.318551 carcinomas cutáneos 0.316845 Estados Unidos 0.319384 Natl Cancer Inst 0.311163 human papillomavirus infection 0.320874 CCE invasor 0.312649 Euros frente 0.310849 N2a Metástasis 0.310265 cell carcinomas 0.926899 escisión frente 0.315633 Arch Dermatol 0.342458	Carcinoma apocrino 0.319357 uncomplicated basal cell 0.313087 Invest Dermatol 0.31893 Mohs micrographic surgery 0.311178 micosis fungoide 0.313548 Cancer Staging Manual 0.594205 recidivas locales 0.316877 PDQ Tratamiento 0.321192 New York 0.409746 Day CL Jr 0.315276 clasificación tnm 0.310941 células escamosas cutáneos 0.311636 Dermatol Surg 0.324225 Byrd DR 0.419056 T2b Tumor 0.314992 Karagas MR 0.311264 basal cell carcinomas 0.750035 American Joint Committee 0.344157 párpadoa aReproducción 0.326393 tumor fotosensibilizadores 0.313881 Tis Carcinoma 0.334823 Carcinoma arising 0.318249 AJCC Cancer Staging 0.604512 Edge SB 0.427178	CLICK HERE
1878	National Cancer Institute	Html	es	Tratamiento del cáncer de seno (mama) masculino (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de seno (mama) masculino.	Giordano SH 0.546628 Italian Oncology Group 0.503266 aromatase inhibitors 0.504835 Sin embargo 0.505052 accessed october 0.502081 American Cancer Society 0.521913 sumario tratamiento 0.50893 PALB2 mutations 0.502161 Terapia sistémica preoperatoria 0.504717 Instituto Nacional 0.507139 Vlamis V 0.505558 male breast 0.773618 DeVita VT Jr 0.502939 Wong GY 0.505822 population-based study 0.506079 carcinoma lobulillar 0.502812 hereditary male breast 0.514858 estadificación tnm 0.502579 Buzdar AU 0.511225 breast carcinoma 0.529746 German Breast Group 0.523976 Adjuvant therapy with 0.503518 male breast carcinoma 0.523697 Cancer Facts 0.511201 parientes mujeres 0.50281	tumores pten 0.506695 Cancer Res Treat 0.581998 National Cancer Institute 0.509524 or without gonadotropin-releasing 0.502999 PDQ Tratamiento 0.571327 versus ia 0.508803 Hortobagyi GN 0.519998 Intern Med 0.505973 cancer susceptibility 0.510328 cases from 0.502419 metastatic breast 0.510618 Clin Oncol 0.505305 IA vs 0.504284 Physician Data Query 0.502682 breast cancer 0.966614 estadios tnm 0.502728 Oncology Group Phase 0.503374 Aromatase inhibitors with 0.503642 PDQ Sofocos 0.507587 Current management 0.505493 Oncology Group 0.504752 Borgen PI 0.505535 Hormonal treatment 0.502423 Breast Cancer Res 0.608904	CLICK HERE
2045	National Cancer Institute	Html	es	Exámenes de detección del cáncer de ovario, de trompas de Falopio y primario de peritoneo (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de ovario, de trompas de Falopio y primario de peritoneo.	Obstet Gynecol 0.429928 United Kingdom Collaborative 0.409268 Bast RC Jr 0.42202 Jacobs IJ 0.404314 ensayo ca-125 0.406196 randomised controlled 0.404882 ovarian cancer algorithm 0.442917 término cáncer 0.410224 Longitudinal screening algorithm 0.406983 American Cancer Society 0.41643 gynecologic cancers 0.414338 Cancer Screening Randomized 0.428277 ensayo plco 0.448316 Kingdom Collaborative Trial 0.414212 ecografía transvaginal 0.498268 serum ca-125 levels 0.405779 Instituto Nacional 0.405706 screening trial specimens 0.40956 ovarian cancer 0.962069 grupo control 0.404575 PDQ Exámenes 0.408591 uk collaborative trial 0.420355 ovarian carcinoma 0.410371 Estados Unidos 0.412447 Natl Cancer Inst 0.419302	Randomized Controlled Trial 0.413244 Partridge E 0.417834 CA-125 velocity 0.404292 PDQ Prevención 0.409813 Gynecol Oncol 0.414371 detección simultáneos 0.410338 SEER Cancer Statistics 0.408582 using transvaginal sonography 0.404548 cohort study 0.404541 marcador sérico ca-125 0.406906 Cancer Facts 0.408569 controlled trial 0.421989 National Cancer Institute 0.418053 Gynecologic Cancer Predisposition 0.409737 collaborative trial 0.433295 Shizuoka Cancer Registry 0.409677 PDQ Genetics 0.404479 Gynecol Cancer 0.409511 cancer screening trial 0.473823 PLCO trial with 0.406621 Screening Randomized Controlled 0.416835 Buys SS 0.413143 ovarian cancer screening 0.679966 mujeres morirán 0.405822	CLICK HERE
3422	National Cancer Institute	Html	es	Reconstrucción del seno después de una mastectomía	Hoja informativa que describe la reconstrucción del seno (mama) después de una mastectomía. Contiene información sobre las opciones quirúrgicas, los cuidados de seguimiento y los exámenes de detección del cáncer de seno después de la reconstrucción.	cirugía abdominal 0.39888 ley whcra 0.35286 Nipple-sparing mastectomy—is it 0.332063 Cordeiro PG 0.320216 colgajo siep 0.393996 Colgajo TRAM 0.39889 suficiente piel 0.387487 largo plazo 0.34858 large cell lymphoma 0.395571 reconstruction following surgery 0.356853 Reconstructive Surgery 0.417753 Colgajo SGAP 0.397479 Colgajo PAP 0.399861 Colgajo Latissimus 0.401399 PubMed Abstract 0.945047 Colgajo TUG 0.398937 colgajo diep 0.587224 Surgical Oncology Clinics 0.338406 Cirugía oncoplástica.  0.339864 La Cruz L 0.324776 NCI titulada Mamografías 0.32023 breast reconstruction 0.705756 colgajo igap 0.469394 pequeños trozos 0.3196 suficiente tejido 0.3777	colgajos ld 0.342761 Colgajo SIEA 0.398955 Da Lio A 0.329732 implantes de solución 0.348682 reconstruction after surgery 0.366752 therapy implications following 0.337385 suficiente volumen 0.324436 reconstrucción retardada 0.559365 Breast reconstruction after 0.445489 reconstruction after mastectomy 0.350953 Petit JY 0.31974 Breast Disease 0.377661 Cancer Rights Act 0.334748 Reviews Clinical Oncology 0.3359 oncoplastic breast-conserving surgery 0.341614 Total skin sparing 0.332343 técnica llamada 0.357673 sensibilidad conforme crecen y 0.339464 anaplastic large cell 0.394345 New England Journal 0.330568 ¿qué tipo 0.325566 physical therapy 0.407423 systematic reviews 0.354768 Surgical Oncology 0.355698	CLICK HERE
16776	National Cancer Institute	Html	es	Cancell/Cantron/Protocel (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre el uso de Cancell/Cantron/Protocel como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	Questionable methods 0.583285 NCI Tumor Cell 0.253187 Alternative Cancer Treatment 0.949939 Cancell Alternative Cancer 0.909029 physiological consequences 0.221271 Dills WL Jr 0.236274 Pedersen PL 0.220212 James V 0.220328 CA Cancer 0.715566 Instituto Nacional 0.460523 Tumor Cell Line 0.306478 Livingston-Wheeler therapy 0.223682 nombre cancell 0.23058 Estados Unidos 0.337461 mutational events that 0.237295 Cassileth BR 0.27252 Complementary Therapies 0.275875 tumour glycolysis 0.221381 Oncogenic alterations 0.222154 NCI-60 DTP Human 0.237422 Eastern District 0.221187 WW Norton 0.271304 Bioenerg Biomembr 0.223121 peso promedio 0.220355 District Court 0.221556	Alternative Medicine Handbook 0.357021 Edmund J 0.22088 United States 0.221128 bacteria p 0.221477 Semenza GL 0.221681 diabetes mellitus 0.223111 llamó entelev 0.224971 tipo cancell 0.228779 vía oral 0.22206 Winter Works 0.543066 Trends Biochem Sci 0.237977 critical role 0.221303 Dang CV 0.220582 Mathupala SP 0.220471 National Cancer Institute 0.327107 Aberrant glycolytic metabolism 0.237912 Permanent Injunction 0.223017 New York 0.262714 accessed april 0.557875 Cell Line Screen 0.307726 Physician Data Query 0.23188 Complete Reference Guide 0.33124 células primitivas resultantes 0.275971 Máxima concentración 0.230742	CLICK HERE
16843	National Cancer Institute	Html	en	Massachusetts General Hospital and Harvard Univeristy — Imaging of Nanotherapeutic Drug Action	In vivo imaging analyses of therapeutic nanoparticles (TNP), addressing key questions on nanoparticle distribution (pharmacokinetics, PK) and cellular response (pharmacodynamics, PD).	nanoparticle distribution 0.841511 enhanced MR imaging 0.924949 biological understanding 0.766676 Alliance members 0.763245 M.D. 0.664358 vivo imaging analyses 0.983793 Claudio Vinegoni 0.829503 Cesar Castro 0.816804 cancer cells 0.772225 NCI Alliance 0.790962 Ph.D 0.666483 project team 0.768015 considerable proportion 0.780069 clinical data 0.766134 recent developments 0.775301 multimodality imaging 0.800032 larger number 0.783733 affinity ligands 0.782978 cancer nanotechnology questions 0.94124 Ralph Weissleder 0.799712 TNP 0.654222 free survival 0.789955 vivo imaging technologies 0.994916 nano-encapsulated chemotherapeutics 0.788661	recent feasibility studies 0.924078 lower toxicity 0.785357 cancer members 0.792525 molecular diagnostics 0.779336 new strategy 0.77113 following questions 0.766532 new constructs 0.797665 new biological insight 0.926895 vivo setting 0.83945 tumoral accumulation 0.816621 temporal heterogeneity 0.803444 key questions 0.775023 future interactions 0.756886 efficacy 0.740414 tumoral myeloid cells 0.915593 Principal Investigators 0.797013 tumor cell accumulation 0.959124 therapeutic nanoparticles 0.774355 molecular / cell 0.763144 occasionally improved progression 0.958519 Mikael Pittet 0.837942 cancer biology 0.77172 Alliance projects 0.764335	CLICK HERE
17186	National Cancer Institute	Html	en	TMIST (Tomosynthesis Mammographic Imaging Screening Trial)	TMIST is a randomized breast screening trial that compares two Food and Drug Administration (FDA)-approved types of digital mammography, standard digital mammography (2-D) with a newer technology called tomosynthesis mammography (3-D).	routine screening mammogram 0.506393 entire study group 0.421549 tomosynthesis mammography 0.449515 health plans 0.41281 3-D mammography 0.660743 trial 0.465454 breast cancer status 0.514295 standard digital mammography 0.512193 3-D mammogram 0.462356 women ages 0.504522 following factors 0.42666 breast biopsies 0.439927 fewer false-positive test 0.416422 researchers 0.394009 2-D screening mammograms 0.502737 mammography clinics 0.435449 aggressive breast cancers 0.493477 ECOG-ACRIN Cancer Research 0.42875 2-D mammography 0.505053 3-D mammograms 0.447984 hormone replacement therapy 0.765582 randomized breast 0.472367 personal risk factors 0.42803 primary care doctors 0.417168 women 0.662197	risk changes 0.412147 fewer harder-to-treat cancers 0.422139 study 0.460399 best ways 0.450667 mammograms 0.529145 age group 0.430585 certain groups 0.456471 breast cancers 0.534289 dense breasts 0.527755 complete cost 0.412269 premenopausal women 0.386263 routine mammogram 0.443785 mammogram 0.569066 3-D mammography machines 0.510266 3-D mammography images 0.549905 breast cancer screening 0.609852 newly diagnosed breast 0.491574 nearby lymph node 0.415404 breast cancer 0.940336 trial record 0.381013 tissue samples 0.430822 genetic changes 0.428717 Women’s health 0.38389 family history 0.510755	CLICK HERE